Zobrazeno 1 - 10
of 192
pro vyhledávání: '"V. Menshikov"'
Publikováno v:
RUDN journal of Sociology, Vol 24, Iss 2, Pp 354-378 (2024)
The article considers the main participants of artificial sociality (people and artificial intelligence tools) and communication between them. The study is predominantly sociological but includes an attempt to address the mathematical-technological a
Externí odkaz:
https://doaj.org/article/91d3be2cd7884de997117de3c997d68c
Publikováno v:
RUDN journal of Sociology, Vol 23, Iss 4, Pp 825-838 (2023)
The article aims at identifying the medium-term fertility trend in Latvia. The main research question is whether it is possible in the near future to increase fertility in Latvia, as planned in the “Strategy for the Reproduction of the Nation FAMIL
Externí odkaz:
https://doaj.org/article/b9a2c31a231b4a9184e72f0aa7f714cb
Publikováno v:
RUDN journal of Sociology, Vol 22, Iss 4, Pp 919-936 (2022)
The study aims at the comparative analysis of the trends in wealth concentration and formation of the ‘patrimonial middle class’ (the term by Piketty) in the countries of the contemporary European-American civilization (EAC). T. Piketty suggests
Externí odkaz:
https://doaj.org/article/3fa381660d8144298c321b834a31fd27
Autor:
V. V. Petkau, A. V. Sultanbaev, K. V. Menshikov, A. S. Antipin, M. V. Volkonsky, V. M. Filippova, Yu. V. Vasilyeva, A. A. Tarkhanov, M. R. Mukhitova, M. Zh. Murzalina, A. R. Safarova
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 32, Iss 4, Pp 75-88 (2022)
Aim. To determine lenvatinib treatment outcomes in patients with advanced unresectable hepatocellular carcinoma (uHCC) in real clinical practice.Patients and methods. A multicenter retrospective observational study included 58 patients with a confirm
Externí odkaz:
https://doaj.org/article/63c0b6ac5e87423bbeab0b4c7ffae672
Autor:
Ainur F. Nasretdinov, Konstantin V. Menshikov, Alexander V. Sultanbaev, Shamil I. Musin, Nadezda I. Sultanbaeva, Irina A. Men'shikova
Publikováno v:
Современная онкология, Vol 24, Iss 3, Pp 340-344 (2022)
Knowledge of the molecular characteristics of the progression of non-small cell lung tumors currently provides the patient with the best treatment options. One of the most well-known and studied genetic abnormalities is a mutation in the EGFR gene, w
Externí odkaz:
https://doaj.org/article/ebd429d188994256bcbd1e16341b2425
Autor:
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. R. Rakhmatullina, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, E. V. Popova, G. A. Serebrennikov
Publikováno v:
Креативная хирургия и онкология, Vol 12, Iss 2, Pp 139-150 (2022)
Liver cancer remains a global challenge of healthcare, with the incidence growing worldwide. According to various authors, over 1 million patients will be diagnosed with liver cancer each year by 2025. The molecular pathogenesis of HCC varies with re
Externí odkaz:
https://doaj.org/article/c14b45b6db8241569154b21ca73ae506
Autor:
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 85-92 (2022)
Metastatic renal cell carcinoma accounts for almost 85% of all cases of malignant neoplasms of the kidney. Sunitinib is an anti-angiogenic tyrosine kinase inhibitor, one of the indications is the treatment of mRCC in adults. Sunitinib is an oral tyro
Externí odkaz:
https://doaj.org/article/061185ac3cf041fd96aab1193bba9ee1
Autor:
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 31-39 (2022)
Hepatocellular carcinoma is a common type of liver malignancy and one of the leading causes of cancer death worldwide. In the Russian Federation, according to statistical reports, there is also an increase in the incidence. For over 10 years, the tyr
Externí odkaz:
https://doaj.org/article/f0334c283a9d448a85d4c09cb7411a4a
Autor:
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, L. A. Khammatova
Publikováno v:
Креативная хирургия и онкология, Vol 12, Iss 1, Pp 48-55 (2022)
Pancreatic adenocarcinoma has a 5-year overall survival rate of 9 %, with an outlook of becoming the second leading cause of cancer mortality in the USA by 2030. Familial pancreatic cancer and genetic predisposition syndromes have attracted more inte
Externí odkaz:
https://doaj.org/article/5b7e6301eb384d58bbc48058fc4843f0
Autor:
Tatyana N. Sokolova, Tatyana I. Solov'eva, Svetlana N. Aleksakhina, Grigorii A. Janus, Alla Goryainova, Mark I. Gluzman, Rashida V. Orlova, Anastasiya I. Stukan, Ruslan A. Zukov, Alena V. Zyuzyukina, Yulia N. Murunova, Aleksandr V. Sultanbaev, Elena N. Vorobeva, Leonid M. Mikhaevich, Victoria N. Pyliv, Anna N. Lysenko, Zarema K. Khachmamuk, Andrey E. Kozlov, Sergey Y. Bakharev, Shahen G. Parsyan, Elena I. Rossokha, Leri D. Osidze, Irina S. Shumskaya, Anna V. Agaeva, Tatiana A. Kasmynina, Veronika V. Klimenko, Kamila T. Akhmetgareeva, Almira A. Vakhitova, Madina D. Chakhkieva, Vadim N. Dmitriev, Yana I. Bakshun, Alexey E. Vasilyev, Dunya D. Gasimly, Nadezhda A. Kravchenko, Dmitriy A. Maksimov, Alfia I. Nesterova, Ineza O. Sharvashidze, Christina H. Gadzaova, Galina G. Rakhmankulova, Zaur M. Khamgokov, Irina K. Amirkhanova, Ludmila V. Bembeeva, Vladimir I. Vladimirov, Oleg L. Petrenko, Natalia G. Ruskova, Ekaterina L. Serikova, Ksenia S. Subbotina, Svetlana A. Tkachenko, Victor L. Chang, Sanal P. Erdniev, Victoria S. Barbara, Anna V. Vasilevskaya, Yulia V. Mikheeva, Nataliya O. Popova, Ekaterina P. Startseva, Anastasia V. Fateeva, Denis Y. Yukalchuk, Anna A. Grechkina, Khedi S. Musaeva, Svetlana V. Odintsova, Alena S. Stel'makh, Petimat I. Khabibulaeva, Alina G. Khlobystina, Kseniya A. Shvaiko, Elena A. Basova, Irina A. Bogomolova, Marina B. Bolieva, Viktor E. Goldberg, Marianna V. Kibisheva, Konstantin V. Menshikov, Dmitrii V. Ryazanov, Mariya L. Stepanova, Yana A. Udalova, Aleksandr V. Shkradyuk, Yana S. Chapko, Anna A. Shchukina, Idris M. Khabriev, Dmitrii V. Kirtbaya, Alexey M. Degtyarev, Aleksandr A. Epkhiev, Yana A. Tyugina, Mirza A. Murachuev, Aleksandr V. Togo, Aglaya G. Ievleva, Evgenii N. Imyanitov
Publikováno v:
Современная онкология, Vol 24, Iss 1, Pp 12-23 (2022)
Background. By 2020, breast cancer (BC) has become the most frequent malignancy in the world. The most common type of BC is HR+/HER2-negative cancer,2540% of which harbors PIK3CA mutations that affect the catalytic subunit of the PI3K protein. PIK3CA
Externí odkaz:
https://doaj.org/article/ac2dc051d6cd4d1686520ce6a60f66af